Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which took place on May 23, 2024, in Marseille. All resolutions were voted.
A total of 84 votes were cast out of a total of 36,317,268 shares giving right to 36,798,714 voting rights, representing a quorum of 44,92%.
During the meeting, two members of the Supervisory Board who were up for election were re-elected.
The resolutions, the results of the votes and other documents relating to the AGM along with the AGM recording will be available in the Annual General Meeting 2024 section of the Company’s website.
| Press Release in English | 162.2 KB |
| Communiqué de presse en français | 144.94 KB |